Related references
Note: Only part of the references are listed.Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
Mark Thaller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
Dun Jack Fu et al.
JAMA OPHTHALMOLOGY (2021)
Digital Technology for AMD Management in the Post-COVID-19 New Normal
Shaun Sebastian Sim et al.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2021)
Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration
David R. P. Almeida et al.
CLINICAL OPHTHALMOLOGY (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK
Simon Ball et al.
HEART (2020)
Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China
Kai-Bo Yang et al.
FRONTIERS IN MEDICINE (2020)
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Sharon D. Solomon et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Vision Rehabilitation Preferred Practice Pattern (R)
Timothy W. Olsen et al.
OPHTHALMOLOGY (2018)
NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS
Jae Hui Kim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Negative outcome Charles Bonnet Syndrome
Thomas M. Cox et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
The estimated prevalence and incidence of late stage age related macular degeneration in the UK
Christopher G. Owen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Risk of Falls, Injurious Falls, and Other Injuries Resulting from Visual Impairment among Older Adults with Age-Related Macular Degeneration
Joanne M. Wood et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
International vision requirements for driver licensing and disability pensions: using a milestone approach in characterization of progressive eye disease
Alain M. Bron et al.
CLINICAL OPHTHALMOLOGY (2010)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
Praveen J. Patel et al.
TRIALS (2008)
Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study
Andrew Lotery et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The impact of diabetic retinopathy on participation in daily living
EL Lamoureux et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?
CG Owen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Share Paper
